VIRTUAL PSYCHEDELICS INC. (VPI) is an innovative multi-disciplinary company that stands at the crossroads of virtual experience and Psychedelics: transformative tools that, when deployed with the right intention, can be used to heal the world. VPI is developing a slate of symbiotic ventures which are designed to bring greater control to psychedelic-assisted therapy, help to frame the story of plant medicine for mainstream understanding and adoption, and sow seeds for content ecosystems that bring the psychedelic community into the Metaverse. Founded by the leading minds in both clinical and entertainment-based Virtual Reality, VPI is dedicated to developing new approaches for the treatment of neurological and psychiatric conditions, and for promoting wellness, alongside the technologies and processes to make them scaleable. Within the psychedelic therapy context, the strategic use of XR to direct or “craft” the user experience is seen as a way to improve clinical outcomes. KRYSALIS INNOVATIONS was formed to deliver headset-free XR while serving as a distribution platform for Clinical/SubClinical XR Content. This immersive system will help manage set and setting in psychedelic therapy environments, and can be the anchor for therapeutic immersive content in the home. VPI’s CLINICAL XR LAB is a production company formed to aggregate and develop XR Content for the Krysalis System, and to anchor VPI’s Research, Development and Production of premium Clinical and Sub-Clinical XR Content. Specialized in experience-crafting, the Lab will pioneer the emerging realm of Medicinal Immersive Media.